388
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Volumetric analysis of the subthalamic and red nuclei based on magnetic resonance imaging in patients with Parkinson's disease

, , , , , , , & show all
Pages 291-295 | Received 04 Aug 2013, Accepted 06 Sep 2013, Published online: 26 Sep 2013

References

  • Wirdefeldt K, Adami HO, Cole P, Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011;26:S1–58.
  • Mitchell IJ, Clarke CE, Boyce S, Neural mechanisms underlying Parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1989;32:213–26.
  • Bergman H, Wichmann T, Karmon B, The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J Neurophysiol 1994;72:507–20.
  • Hassani OK, Mouroux M, Feger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 1996;72:105–15.
  • Tai CH, Boraud T, Bezard E, Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J 2003;17:1820–30.
  • Vila M, Levy R, Herrero MT, Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 1997;15:765–73.
  • Winn HR. Subthalamic deep brain stimulation for Parkinson's disease. In: Winn HR ed. Youmans neurological surgery, 6th ed. Philadelphia: Elsevier; 2011: 944–62.
  • Rodriguez-Oroz MC, Rodriguez M, Guridi J, The subthalamic nucleus in Parkinson's disease: somatotopic organisation and physiological physiological characteristics. Brain 2001;124:1777–90.
  • Yelnik J. Functional anatomy of the basal ganglia. Mov Disord 2002;17:15–21.
  • Elolf E, Bockermann V, Gringel T, Improved visibility of the subthalamic nucleus on high resolution stereotactic MR imaging by added susceptibility (T2*) contrast using multiple gradient echoes. AJNR Am J Neuroradiol 2007;28:1093–4.
  • Kerl HU, Gerigk L, Pechlivanis I, The subthalamic nucleus at 7.0 Tesla: evaluation of sequence and orientation for deep brain stimulation. Acta Neurochir (Wien) 2012;154:2051–62.
  • Kerl HU, Gerigk L, Pechlivanis I, The subthalamic nucleus at 3.0 Tesla: choice of optimal sequence and orientation for deep brain stimulation using a standard installation protocol: clinical article. J Neurosurg 2012;117:1155–65.
  • Vertinsky AT, Coenen VA, Lang DJ, Localisation of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging. AJNR Am J Neuroradiol 2009;30: 1717–24.
  • Slavin KV, Thulborn KR, Wess C, Direct visualization of the human subthalamic nucleus with 3 T MR imaging. AJNR Am J Neuroradiol 2006;27:80–4.
  • Kitajima M, Korogi Y, Kakeda S, Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0 T. Neuroradiology 2008;50:675–81.
  • Sedrak M, Gorgulho A, Bari A, Diffusion tensor imaging (DTI) and colored fractional anisotropy (FA) mapping of the subthalamic nucleus (STN) and globus pallidus interna (GPi). Acta Neurochir (Wien) 2010;152:2079–84.
  • Pollo C, Meuli R, Maeder P, Subthalamic nucleus deep brain stimulation for Parkinson's disease: magnetic resonance imaging targeting using visible anatomical landmarks. Stereotact Funct Neurosurg 2003;80:76–81.
  • Bejjani BP, Dormont D, Pidoux B, Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurgery 2000;92:615–25.
  • Habas C, Cabanis EA. Cortical projections to the human red nucleus: a diffusion tensor tractography study with a 1.5-T MRI machine. Neuroradiology 2006;48:755.
  • Rodriguez-Oroz MC, Rodriguez M, Leiva C, Neuronal activity of the red nucleus in Parkinson's disease. Mov Disord 2008;30:908–11.
  • Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368–76.
  • Daniluk S, G Davies K, Ellias SA, Assessment of the variability in the anatomical position and size of the subthalamic nucleus among patients with advanced Parkinson's disease using magnetic resonance imaging. Acta Neurochir (Wien) 2010;152:201–10.
  • Patel NK, Khan S, Gill SS. Comparison of atlas and magnetic-resonance-imaging-based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson's disease. Stereotact Funct Neurosurg 2008;86:153–61.
  • Schulz JB, Skalej M, Wedekind D, Magnetic resonance imaging based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65–74.
  • Colpan ME, Slavin KV. Subthalamic and red nucleus volumes in patients with Parkinson's disease: do they change with disease progression? Parkinsonism Relat Disord 2010;16: 398–403.
  • Geng DY, Li YX, Zee CS. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006; 58:256–62.
  • Bonneville F, Welter ML, Elie C, Parkinson disease, brain volumes, and subthalamic nucleus stimulation. Neurology 2005;64:1598–604.
  • Pitcher TL, Melzer TR, Macaskill MR, Reduced striatal volumes in Parkinson's disease: a magnetic resonance imaging study. Transl Neurodegener 2012;1:17.
  • O'Neill J, Schuff N, Marks WJ, Jr, Ouantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 2002;17:917–27.
  • Richter EO, Hoque T, Halliday W, Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg 2004;100:541–6.
  • Massey LA, Yousry TA. Anatomy of the substantia nigra and subthalamic nucleus on MR imaging. Neuroimaging Clin N Am 2010;20:7–27.
  • Toda H, Sawamoto N, Hanakawa T, A novel composite targeting method using high-field magnetic resonance imaging for subthalamic nucleus deep brain stimulation. J Neurosurg 2009;111:737–45.
  • Carpenter M, Sutin J. Human neuroanatomy. 8th ed. Baltimore, MD: Williams & Wilkins; 1983.
  • Hardman CD, Halliday GM, McRitchie DA, The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 1997;56:132–42.
  • Habas C, Cabanis EA. Cortical projections to the human red nucleus: a diffusion tensor tractography study with a 1.5-T MRI machine. Neuroradiology 2006;48:755e62.
  • Koch G, Brusa L, Carrillo F, et. al. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology 2009;73:113–9.
  • Sen S, Kawaguchi A, Truong Y, Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease. Neuroscience 2010;166:712–9.
  • Lewis MM, Du G, Kidacki M, Higher iron in the red nucleus marks Parkinson's dyskinesia. Neurobiol Aging 2013;34:1497–503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.